Litcius/Paper detail

Serum Aberrant Expression of miR-24-3P and Its Diagnostic Value in Alzheimer’s Disease

Lina Liu, Luran Liu, Yunting Lu, Tianyuan Zhang, Wenting Zhao

2021Biomarkers in Medicine30 citationsDOI

Abstract

Aim: This study aimed to evaluate the effect of miR-24-3p in Alzheimer’s disease (AD). Materials & methods: A total of 198 participants were recruited in this study, including 104 AD patients and 94 healthy controls. Expression of miR-24-3p was detected using quantitative real-time PCR. Receiver-operating characteristic curve was used to assess the diagnostic value of miR-24-3p. In vitro AD model was established to evaluate the effect of miR-24-3p. The downstream target was detected by luciferase reporter gene assay. Results: Expression of miR-24-3p showed 1.6-fold increase in AD group compared with healthy controls, and a negative correlation of miR-24-3p with mini-mental state examination score was obtained. Receiver-operating characteristic curve showed satisfactory diagnostic accuracy. Downregulation of miR-24-3p promoted cell proliferation and inhibited cell apoptosis. KLF8 is a target gene of miR-24-3p. Conclusion: MiR-24-3p has a certain value in the diagnosis of AD and may be a potential biomarker.

Topics & Concepts

Receiver operating characteristicMedicineBiomarkerDownregulation and upregulationDiseaseApoptosismicroRNAReal-time polymerase chain reactionDiagnostic accuracyAlzheimer's diseaseCancer researchOncologyDiagnostic biomarkerGeneInternal medicineBiologyGeneticsMicroRNA in disease regulationAlzheimer's disease research and treatmentsRNA regulation and disease
Serum Aberrant Expression of miR-24-3P and Its Diagnostic Value in Alzheimer’s Disease | Litcius